| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4467721
Max Phase: Preclinical
Molecular Formula: C23H31N3O4
Molecular Weight: 413.52
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: COc1cc2c(cc1OCCCC(=O)NC1CCCCC1)N=C[C@@H]1CCCN1C2=O
Standard InChI: InChI=1S/C23H31N3O4/c1-29-20-13-18-19(24-15-17-9-5-11-26(17)23(18)28)14-21(20)30-12-6-10-22(27)25-16-7-3-2-4-8-16/h13-17H,2-12H2,1H3,(H,25,27)/t17-/m0/s1
Standard InChI Key: GQCQHLNCIIZLIN-KRWDZBQOSA-N
Associated Targets(Human)
JJN-3 67 Activities
B cell 126 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 413.52 | Molecular Weight (Monoisotopic): 413.2315 | AlogP: 3.62 | #Rotatable Bonds: 7 |
| Polar Surface Area: 80.23 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 4.06 | CX LogP: 2.30 | CX LogD: 2.30 |
| Aromatic Rings: 1 | Heavy Atoms: 30 | QED Weighted: 0.69 | Np Likeness Score: -0.35 |
References
| 1. Corcoran DB, Lewis T, Nahar KS, Jamshidi S, Fegan C, Pepper C, Thurston DE, Rahman KM.. (2019) Effects of Systematic Shortening of Noncovalent C8 Side Chain on the Cytotoxicity and NF-κB Inhibitory Capacity of Pyrrolobenzodiazepines (PBDs)., 62 (4): [PMID:30688457] [10.1021/acs.jmedchem.8b01849] |
Source
Source(1):